S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

APLT Applied Therapeutics Inc

4.28

0.05 (1.18%)

27 Apr 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Applied Therapeutics Charts.

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Applied Therapeutics Charts.

Applied Therapeutics Inc News

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Monday 15 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
Thursday 4 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Applied Therapeutics Announces $100 Million Private Placement
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

More Applied Therapeutics Inc News Articles

Australia And New Zealan...

Woodside Petroleum

JP Morgan Chase

Invesco QQQ Trust Series 1

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions